These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4925903)

  • 21. Adoptive immunotherapy and chemo-immunotherapy in murine L-1210 leukemia and its influence on the kinetics of leukemic proliferation.
    Rytwiński K
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):819-27. PubMed ID: 549532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H; Good RA
    Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
    Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantability of leukaemia from leukaemic mice after irradiation and injection of allogeneic spleen cells.
    Boranić M
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):104-9. PubMed ID: 4909999
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of the effects of the total irradiation-methylhydrazine combination and total irradiation alone for the eradication of transplanted L 1210 leukemia treated by adoptive immunotherapy].
    Choquet C; Rosenkovitch E; Halle-Pannenko O; Crochet MF; Florentin I
    Rev Fr Etud Clin Biol; 1966 Mar; 11(3):298-301. PubMed ID: 5326626
    [No Abstract]   [Full Text] [Related]  

  • 26. Allogeneic marrow grafting for acute lymphoblastic leukemia: leukemic relapse.
    Storb R; Bryant JI; Buckner CD; Clift RA; Fefer A; Fialkow PJ; Johnson FL; Neiman P; Thomas ED
    Transplant Proc; 1973 Mar; 5(1):923-6. PubMed ID: 4572153
    [No Abstract]   [Full Text] [Related]  

  • 27. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
    Boranić M; Tonković I
    Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
    [No Abstract]   [Full Text] [Related]  

  • 28. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
    Saltzstein EC; Glasspiegel JS; Rimm AA; Giller RH; Bortin MM
    Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R; Bony V; Lopez M
    Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
    Pazdernik TL; Uyeki EM
    J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transplantation of allogeneic bone marrow and spleen in lethally irradiated dogs].
    Rogacheva LS; Shepshelevich LL; Sukiasian GV; Chertkov IL
    Probl Gematol Pereliv Krovi; 1972 Aug; 17(8):39-44. PubMed ID: 4569506
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of a new interferon inducer and leukocyte interferon for a significant enhancement of the immunocytotherapy of leukemia in mice].
    Madzhidov AV; Poverennyĭ AM; Popov GA; Fuks BB
    Biull Eksp Biol Med; 1983 Jan; 95(1):63-5. PubMed ID: 6830962
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.
    Nicolin A; Canti G; Marelli O; Veronese F; Goldin A
    Cancer Res; 1981 Apr; 41(4):1358-62. PubMed ID: 7011535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
    Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
    J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed mortality in sublethally irradiated mice treated with allogeneic lymphoid and myeloid cells.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):439-50. PubMed ID: 4876446
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
    Young RC; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
    [No Abstract]   [Full Text] [Related]  

  • 37. Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukaemia and Lewis tumour.
    Mathé G; Halle-Pannenko O; Bourut C
    Eur J Cancer (1965); 1977 Oct; 13(10):1095-8. PubMed ID: 923609
    [No Abstract]   [Full Text] [Related]  

  • 38. Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.
    Zagozdzon R; Gołab J; Stokłosa T; Giermasz A; Nowicka D; Feleszko W; Lasek W; Jakóbisiak M
    Int J Cancer; 1998 Aug; 77(5):720-7. PubMed ID: 9688305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on transplantation of bone marrow and spleen cells.
    Munakata K
    Nagoya J Med Sci; 1966 Dec; 29(2):129-38. PubMed ID: 4862013
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
    Weiss L; Nusair S; Reich S; Sidi H; Slavin S
    Cancer Immunol Immunother; 1996 Oct; 43(2):103-8. PubMed ID: 8954144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.